Seattle Genetics/Takeda’s Adcetris to treat Hodgkin’s lymphoma, cancer of the lymph nodes, will continue to lead the market in the United States, opines an analyst.
Gastrointestinal Stromal Tumors may Lead to Cancers Outside Their Syndromes
Patients with GST are more likely to develop other sarcomas, melanoma, colorectal, esophageal, pancreatic, prostate and renal cell cancers.
Patients with GST are more likely to develop other sarcomas, melanoma, colorectal, esophageal, pancreatic, prostate and renal cell cancers.
‘A GlobalData analyst opines that Seattle Genetics/Takeda’s Adcetris to treat Hodgkin’s lymphoma, cancer of the lymph nodes, will continue to lead the market in the United States in 2016.’
Tzellos says the therapy was lauded at the recent 2015 American Society of Hematology (ASH) Meeting and Exposition held in Orlando, Florida. “Adcetris, a CD30-targeting agent, demonstrated a remarkable increase in progression-free survival (PFS) compared with placebo in the new post-autologous transplantation setting. Data presented at ASH indicated that the median PFS was not reached in the Adcetris-treatment arm, while it was less than 16 months in the placebo arm. GlobalData expects that these new data will propel Adcetris towards regulatory approval in Europe in early 2016, leading to its rapid uptake in the Hodgkin’s lymphoma treatment space. The size of the Adcetris target patient population will expand, and Seattle Genetics hopes this will support its goal to establish the therapy as the foundation of care for Hodgkin’s lymphoma,” Tzellos explains.
Meanwhile, Bristol-Myers Squibb (BMS) and Merck and Co., will race to bring their anti-PD-1 therapies to the Hodgkin’s lymphoma arena. The two major pharmaceutical companies presented clinical trial data at ASH. Also, BMS’s Opdivo is slightly better than Merck’s Keytruda in terms of clinical efficacy.
Childhood Cancer Survivors Face Increased Second Cancer Risk, Earlier Death
Survivors of childhood cancer in Australia are at an increased risk of second cancers and an earlier death.
Survivors of childhood cancer in Australia are at an increased risk of second cancers and an earlier death.
Advertisement
Pancreas Cancer Liquid Biopsy Flows from Blood-Borne Packets
Conducting biopsies during treatment would more closely monitor therapy success or failure and help researchers better understand how the cancer genome evolves.
Conducting biopsies during treatment would more closely monitor therapy success or failure and help researchers better understand how the cancer genome evolves.
Mental Health Status Prior to Bladder Cancer Surgery Influences Postoperative Outcomes
Patients whose self-assessment of mental health was low suffered more high grade complications in the 30 days following radical cystectomy.
Patients whose self-assessment of mental health was low suffered more high grade complications in the 30 days following radical cystectomy.
